Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
The Simcyp on-site education program provides bespoke simulator-training sessions at the client’s site. The program caters for small groups of scientists with specific training requests and support, through to larger workshop-style sessions which will be tailored to your specific requirements.
The program is resourced by experienced members of the Simcyp R&D Team who have extensive experience in developing customised material for, and tutoring at, the Simcyp workshops. Experience in multiple consultancy projects and the provision of expert scientific support will ensure that all clients receive a specialised and invaluable education program.
Prior to arranging the on-site education program, two of Simcyp’s Principal Scientist’s, Dr Devendre Pade and Dr Matthew Harwood, work closely with clients to assess their needs and ensure the most effective format and material is provided for the education program.
With 14 years of experience in developing the Simcyp Simulator, they have in-depth knowledge on the functionality, utility and scope of the Simcyp platform. This combination of experience means they are perfectly placed to provide high quality tutoring on the application and future potential of the Simulator in drug development.
For further information please contact us.